Barclays Issues Positive Forecast for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX - Get Free Report) had its target price raised by equities researchers at Barclays from $130.00 to $140.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has an "underweight" rating on the stock. Barclays's price target indicates a potential downside of 5.73% from the stock's previous close.

A number of other research firms have also recently commented on CLX. StockNews.com cut Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Royal Bank of Canada reissued a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. DA Davidson reduced their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research note on Wednesday. TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and upped their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, Evercore ISI raised their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $158.21.

Clorox Price Performance

Shares of NYSE CLX traded up $0.91 during mid-day trading on Wednesday, reaching $148.51. The company had a trading volume of 1,074,015 shares, compared to its average volume of 1,380,263. The firm has a market cap of $18.38 billion, a price-to-earnings ratio of 40.58, a PEG ratio of 2.52 and a beta of 0.42. The business's 50-day simple moving average is $161.06 and its 200 day simple moving average is $158.88. Clorox has a one year low of $127.60 and a one year high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the firm posted $2.16 earnings per share. On average, research analysts predict that Clorox will post 7.15 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Czech National Bank grew its stake in Clorox by 6.6% in the third quarter. Czech National Bank now owns 25,232 shares of the company's stock valued at $4,111,000 after acquiring an additional 1,567 shares during the period. GAMMA Investing LLC increased its position in shares of Clorox by 63.0% during the third quarter. GAMMA Investing LLC now owns 1,795 shares of the company's stock worth $292,000 after acquiring an additional 694 shares in the last quarter. Axiom Advisory LLC increased its holdings in Clorox by 1.6% during the 3rd quarter. Axiom Advisory LLC now owns 11,328 shares of the company's stock worth $1,679,000 after purchasing an additional 177 shares in the last quarter. SL Advisors LLC purchased a new stake in Clorox in the 3rd quarter valued at $188,000. Finally, Wealth Group Ltd. bought a new position in shares of Clorox during the third quarter valued at about $231,000. Institutional investors and hedge funds own 78.53% of the company's stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.